Innovating Works

ONENA MEDICINES

Activa
PTQ2019-010780: Mapa de Interactoma del factor de crecimiento transformante beta a Nivel resiDual (MIND) ONENA MEDICINES tramitó un AEI: 2019-01-01 | Financiado
PTQ2019-010729: Desarrollo y caracterización de anticuerpos de primera clase para el tratamiento del cáncer de mama recurrente ONENA MEDICINES tramitó un AEI: 2019-01-01 | Financiado
Tumor-Treg-Targeting: Training Network for the education of the next generation scientist in targeting the supressive capacity of regulatory T-cells specifically within tumours UNIVERSIDAD DE NAVARRA tramitó un H2020: Tumour immune-therapy has made dramatic improvements in recent years, saving the lives of cancer patients who just afew years ago would have been considered untreatable. It thereby became apparent tha...
2018-06-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.